TAG:
test utilization
New Market Channel For Esoteric Testing
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab direc…
High Cost of New Assays Stretching Lab Budgets
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: Growing numbers of hospital labs report that higher costs of new diagnostic tests have become a new management problem. That’s because diagnostic manufacturers are developing tests around a new business model, one that calls for higher pricing based on a premise of higher c…
Clinical Decision Support Systems Arrive
By R. Lewis Dark | From the Volume IX No. 5 – April 1, 2002 Issue
FORWARD THINKERS IN CLINICAL LABORATORIES and anatomic pathology groups have always recognized the substantial, but as yet unharvested, potential that would accrue to the healthcare system were clinicians to make better use of laboratory testing. All of us know stories and anecdotes about how certai…
Clinical Decision Support System Improves Lab Test Ordering
By Robert Michel | From the Volume IX No. 5 – April 1, 2002 Issue
CEO SUMMARY: Vanderbilt University Medical Center’s “WizOrder” demonstrates that a well-designed clinical decision support system can help physicians make better use of laboratory tests. The early successes of WizOrder demonstrate that the need for improved utilization and applicati…
Beckman Coulter Positions Itself For Biotech Testing Continuum
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: Here’s a little-known side to diagnostics giant Beckman Coulter Inc. Its efforts to expand into the fields of biomedical R&D and clinical research is a strategic shift designed to give it early access to promising technology that could be introduced into the clinical di…
NYC Lab Hand-Entered Reqs After Terrorist Acts
By Robert Michel | From the Volume VIII No. 14 – October 15, 2001 Issue
CEO SUMMARY: Crisis management was the watchword at Centralized Laboratory Services, Inc. of New York City following the terrorist attacks on September 11. Damage around the World Trade Center knocked out the communications link between the lab and a data server which transmitted electron…
Big Jump Predicted In Health Insurance Costs
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
CEO SUMMARY: Spiraling health costs are about to become a headline issue once again. There is widespread evidence that health insurers are seeking premium increases of 20% from the nation’s biggest employers. Aetna recently announced a second quarter 2001 operating loss of $95.9 million…
8 “Must Have” Features For Web Lab Test Reports
CEO SUMMARY: A growing number of laboratories have implemented Web-accessed lab test reporting for their office-based physician clients. Having participated in the design, sale and installation of many of these systems, Cory Fishkin gained valuable insights into the “do’s & don’…
“July 23, 2001 Intelligence: Late Breaking Lab News”
Chairman and CEO Mark Chandler recently disclosed that researchers within Luminex Corporation are developing new detection capabilities that would permit its LabMap system to “simultaneously perform a broad range of cellular, microbial, and related tests, such as complete blood cou…
MCOs Asking For More Lab Test Information
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: During the past 12 months, managed care companies in Michigan have increased the quantity and quality of the laboratory test information they want from their laboratory providers. Once again, the marketplace is raising the bar for competitive laboratory services. In response,…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized